14.30 USD
▲+0.10+0.56%
2026-08-03
市值
$183.79M
市盈率
—
EPS
-2.19
股息率
—
52 周区间
13.54 – 20.30
成交量
66.89K
Beta
0.14
目标价
30.17
52W 低 13.5452W 高 20.30
价格走势
公司简介
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other ...